What is Rune Labs?
Rune Labs operates as a sophisticated software and data analytics enterprise dedicated to the advancement of precision neurology. At the core of its product suite is StrivePD, a comprehensive care delivery ecosystem designed specifically for Parkinson's disease. This platform empowers clinicians and patients alike by synthesizing complex patient data into actionable dashboards, thereby facilitating more informed treatment decisions and streamlining access to clinical trials.
Beyond direct patient care, Rune Labs provides essential utility for biopharma and medical device developers. By offering access to a vast network of engaged clinicians and high-fidelity longitudinal datasets, the company accelerates the development of novel therapeutics. This dual-sided business model—supporting both the clinical frontline and the research laboratory—establishes Rune Labs as a foundational entity in the digital health landscape, capable of transforming how neurological conditions are understood and treated on a global scale.
How much funding has Rune Labs raised?
Rune Labs has raised a total of $51M across 4 funding rounds:
Angel/Seed
$5M
Series A
$22.8M
Other Financing Round
$12M
Private Equity
$11.2M
Angel/Seed (2020): $5M with participation from Moment Ventures, TruVenturo, Loup Ventures, DigiTx Partners, and Sabbatical Ventures
Series A (2021): $22.8M led by DigiTx Partners, Moment Ventures, and Eclipse Ventures
Other Financing Round (2024): $12M supported by Nexus NeuroTech Ventures
Private Equity (2025): $11.2M, investors not publicly disclosed
Key Investors in Rune Labs
Moment Ventures
Moment Ventures is an early-stage venture capital firm based in Palo Alto, focusing on investing in entrepreneurs who are reimagining the future of various industries through innovative technology solutions.
DigiTx Partners
DigiTx Partners is a venture capital firm that focuses on investing in early-stage companies within the digital health sector, emphasizing personalized medicine and data-driven therapeutics.
Eclipse Ventures
Eclipse Ventures is a specialized investment firm that partners with entrepreneurs to build companies that transform physical industries through the integration of software and hardware.
What's next for Rune Labs?
With the successful closure of this major enterprise-level funding, Rune Labs is well-positioned to deepen its investment in data infrastructure and expand its clinical trial recruitment capabilities. The strategic focus will likely shift toward enhancing the predictive power of its analytics engine, allowing for more granular insights into disease progression and treatment efficacy. Furthermore, the company is expected to strengthen its partnerships with major biopharma entities, potentially broadening its therapeutic focus beyond Parkinson's disease into other complex neurological disorders. As the digital health market matures, Rune Labs' ability to harmonize real-world evidence with clinical research will be a primary driver of its long-term competitive advantage and market penetration.
See full Rune Labs company page
